FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2910972034> ?p ?o ?g. }

• W2910972034 abstract "Abstract At the MONARCH 3 interim analysis, abemaciclib plus a nonsteroidal aromatase inhibitor (AI) significantly improved progression-free survival (PFS) and objective response rate (ORR) with a tolerable safety profile as initial treatment for hormone receptor-positive (HR+), human epidermal growth factor receptor 2-negative (HER2−) advanced breast cancer (ABC). MONARCH 3 is a randomized, phase III, double-blind study of abemaciclib/placebo (150 mg twice daily, continuous) plus nonsteroidal AI (1 mg anastrozole or 2.5 mg letrozole, daily). A total of 493 postmenopausal women with HR+, HER2− ABC with no prior systemic therapy in this setting were enrolled. The primary endpoint was investigator-assessed PFS (final analysis after 240 events); other endpoints included response and safety evaluations. Here we analyze the final PFS data and update secondary endpoints. The abemaciclib arm had a significantly longer median PFS than the placebo arm (28.18 versus 14.76 months; hazard ratio [95% confidence interval], 0.540 [0.418–0.698]; p = .000002). The ORR was 61.0% in the abemaciclib arm versus 45.5% in the placebo arm (measurable disease, p = .003). The median duration of response was longer in the abemaciclib arm (27.39 months) compared to the placebo arm (17.46 months). The safety profile was consistent with previous reports. The most frequent grade ≥ 3 adverse events in the abemaciclib versus placebo arms were neutropenia (23.9% versus 1.2%), diarrhea (9.5% versus 1.2%), and leukopenia (8.6% versus 0.6%). Abemaciclib plus a nonsteroidal AI was an effective initial treatment with an acceptable safety profile for HR+, HER2− ABC." @default.
• W2910972034 created "2019-01-25" @default.
• W2910972034 creator A5001838875 @default.
• W2910972034 creator A5008549101 @default.
• W2910972034 creator A5008665323 @default.
• W2910972034 creator A5010064853 @default.
• W2910972034 creator A5010310316 @default.
• W2910972034 creator A5012187098 @default.
• W2910972034 creator A5015712277 @default.
• W2910972034 creator A5028906808 @default.
• W2910972034 creator A5031915637 @default.
• W2910972034 creator A5035054317 @default.
• W2910972034 creator A5040919295 @default.
• W2910972034 creator A5091245889 @default.
• W2910972034 creator A5091553792 @default.
• W2910972034 date "2019-01-17" @default.
• W2910972034 modified "2023-10-16" @default.
• W2910972034 title "MONARCH 3 final PFS: a randomized study of abemaciclib as initial therapy for advanced breast cancer" @default.
• W2910972034 cites W1979301447 @default.
• W2910972034 cites W1979479754 @default.
• W2910972034 cites W1991276289 @default.
• W2910972034 cites W1991601194 @default.
• W2910972034 cites W2012502745 @default.
• W2910972034 cites W2057735943 @default.
• W2910972034 cites W2061515693 @default.
• W2910972034 cites W2079941948 @default.
• W2910972034 cites W2090186935 @default.
• W2910972034 cites W2096979580 @default.
• W2910972034 cites W2136536672 @default.
• W2910972034 cites W2148345265 @default.
• W2910972034 cites W2166602936 @default.
• W2910972034 cites W2273239127 @default.
• W2910972034 cites W2290950904 @default.
• W2910972034 cites W2318409999 @default.
• W2910972034 cites W2560635244 @default.
• W2910972034 cites W2612124029 @default.
• W2910972034 cites W2614543224 @default.
• W2910972034 cites W2617437931 @default.
• W2910972034 cites W2620993107 @default.
• W2910972034 cites W2750328162 @default.
• W2910972034 cites W2757511999 @default.
• W2910972034 cites W2763875663 @default.
• W2910972034 cites W2769376007 @default.
• W2910972034 cites W2775411066 @default.
• W2910972034 cites W2789574985 @default.
• W2910972034 cites W2790403412 @default.
• W2910972034 cites W3041269916 @default.
• W2910972034 doi "https://doi.org/10.1038/s41523-018-0097-z" @default.
• W2910972034 hasPubMedCentralId "https://www.ncbi.nlm.nih.gov/pmc/articles/6336880" @default.
• W2910972034 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/30675515" @default.
• W2910972034 hasPublicationYear "2019" @default.
• W2910972034 type Work @default.
• W2910972034 sameAs 2910972034 @default.
• W2910972034 citedByCount "298" @default.
• W2910972034 countsByYear W29109720342019 @default.
• W2910972034 countsByYear W29109720342020 @default.
• W2910972034 countsByYear W29109720342021 @default.
• W2910972034 countsByYear W29109720342022 @default.
• W2910972034 countsByYear W29109720342023 @default.
• W2910972034 crossrefType "journal-article" @default.
• W2910972034 hasAuthorship W2910972034A5001838875 @default.
• W2910972034 hasAuthorship W2910972034A5008549101 @default.
• W2910972034 hasAuthorship W2910972034A5008665323 @default.
• W2910972034 hasAuthorship W2910972034A5010064853 @default.
• W2910972034 hasAuthorship W2910972034A5010310316 @default.
• W2910972034 hasAuthorship W2910972034A5012187098 @default.
• W2910972034 hasAuthorship W2910972034A5015712277 @default.
• W2910972034 hasAuthorship W2910972034A5028906808 @default.
• W2910972034 hasAuthorship W2910972034A5031915637 @default.
• W2910972034 hasAuthorship W2910972034A5035054317 @default.
• W2910972034 hasAuthorship W2910972034A5040919295 @default.
• W2910972034 hasAuthorship W2910972034A5091245889 @default.
• W2910972034 hasAuthorship W2910972034A5091553792 @default.
• W2910972034 hasBestOaLocation W29109720341 @default.
• W2910972034 hasConcept C121608353 @default.
• W2910972034 hasConcept C126322002 @default.
• W2910972034 hasConcept C141071460 @default.
• W2910972034 hasConcept C142724271 @default.
• W2910972034 hasConcept C143998085 @default.
• W2910972034 hasConcept C168563851 @default.
• W2910972034 hasConcept C197934379 @default.
• W2910972034 hasConcept C203092338 @default.
• W2910972034 hasConcept C204787440 @default.
• W2910972034 hasConcept C207103383 @default.
• W2910972034 hasConcept C27081682 @default.
• W2910972034 hasConcept C2775930923 @default.
• W2910972034 hasConcept C2776215463 @default.
• W2910972034 hasConcept C2776694085 @default.
• W2910972034 hasConcept C2777063308 @default.
• W2910972034 hasConcept C2777176818 @default.
• W2910972034 hasConcept C44249647 @default.
• W2910972034 hasConcept C530470458 @default.
• W2910972034 hasConcept C61943457 @default.
• W2910972034 hasConcept C71924100 @default.
• W2910972034 hasConcept C90924648 @default.
• W2910972034 hasConceptScore W2910972034C121608353 @default.
• W2910972034 hasConceptScore W2910972034C126322002 @default.
• W2910972034 hasConceptScore W2910972034C141071460 @default.
• W2910972034 hasConceptScore W2910972034C142724271 @default.
• W2910972034 hasConceptScore W2910972034C143998085 @default.

• next